6533b82afe1ef96bd128b853
RESEARCH PRODUCT
Pulmonary emphysema in cystic fibrosis detected by densitometry on chest multidetector computed tomography.
Monika EichingerMichael PuderbachClaus Peter HeußelM. WiebelHans-ulrich KauczorJürgen BiedererMarcus A. MallOliver WeinheimerOliver WeinheimerMark O. Wielpützsubject
AdultMalemedicine.medical_specialtyAdolescentCystic FibrosisScienceCystic fibrosisPulmonary function testingHounsfield scaleMultidetector computed tomographyMedicineHumansLung volumesChildAgedEmphysemaMultidisciplinaryLungbusiness.industryQCase-control studyRMiddle Agedrespiratory systemmedicine.diseaserespiratory tract diseasesmedicine.anatomical_structureCase-Control StudiesMedicineFemaleRadiologybusinessDensitometryTomography X-Ray ComputedResearch Articledescription
BackgroundHistopathological studies on lung specimens from patients with cystic fibrosis (CF) and recent results from a mouse model indicate that emphysema may contribute to CF lung disease. However, little is known about the relevance of emphysema in patients with CF. In the present study, we used computationally generated density masks based on multidetector computed tomography (MDCT) of the chest for non-invasive characterization and quantification of emphysema in CF.MethodsVolumetric MDCT scans were acquired in parallel to pulmonary function testing in 41 patients with CF (median age 20.1 years; range 7-66 years) and 21 non-CF controls (median age 30.4 years; range 4-68 years), and subjected to dedicated software. The lung was segmented, low attenuation volumes below a threshold of -950 Hounsfield units were assigned to emphysema volume (EV), and the emphysema index was computed (EI). Results were correlated with forced expiratory volume in 1 s percent predicted (FEV1%), residual volume (RV), and RV/total lung capacity (RV/TLC).ResultsWe show that EV was increased in CF (457±530 ml) compared to non-CF controls (78±90 ml) (PConclusionsOur results indicate that early onset emphysema detected by densitometry on chest MDCT is a characteristic pathology that contributes to airflow limitation and may serve as a novel endpoint for monitoring lung disease in CF.
year | journal | country | edition | language |
---|---|---|---|---|
2013-08-01 | PLoS ONE |